Literature DB >> 7924471

Mononuclear cells in exudative malignant pleural effusions. Characterization of pleural phagocytic cells.

M Gjomarkaj1, E Pace, M Melis, M Spatafora, G B Toews.   

Abstract

The aims of this study were to develop a methodology for the isolation of highly enriched mononuclear phagocyte populations from exudative malignant pleural effusions (EMPE) and to characterize the phenotype and functional properties of these cells. Pleural effusion mononuclear cells (PEMC) were isolated by Ficoll centrifugation of EMPE and transudative pleural effusions and allowed to adhere to plastic for 1 h to obtain a pleural effusion mononuclear adherent cell (PEMAC) fraction. Only 66.0 +/- 4.2 percent of PEMAC ingested latex particles, indicating that a significant proportion of PEMAC were not phagocytic cells. Latex-positive PEMAC had the morphologic appearance of macrophages and stained positive (97.3 +/- 4.3 percent) with the anti-CD68 monoclonal antibody (MoAb), specific for macrophages. Conversely, latex-negative PEMAC (34.0 +/- 4.1 percent of PEMAC) did not react with the anti-CD68 MoAb and stained with anti-CD3 (34.7 +/- 10.7 percent) and anticytokeratin (50.5 +/- 16.4 percent) MoAbs, indicating that T cells and mesothelial cells were present in the PEMAC fraction. To improve the purification of pleural macrophages, PEMAC were cultured for an additional 18 h and the cells that remained adherent after this period constituted the firmly adherent mononuclear cell (FAMC) fraction. Nearly 90 percent of FAMC ingested latex particles and were CD68-positive. Virtually all FAMC were CD3-negative and cytokeratin-negative. Similar percentages of FAMC from EMPE and transudative effusions expressed the monocyte-lineage markers CD11b and CD14, suggesting that the proportion of monocyte-like mononuclear phagocytes in the pleural space is not increased during local tumor-associated inflammatory responses. The FAMC from EMPE (1) expressed HLA-DR antigens, (2) released interleukin 1 (IL-1) beta and tumor necrosis factor (TNF) alpha, and (3) stimulated allogeneic T-lymphocyte proliferation. The results of this study suggest that pleural mononuclear phagocytes may be involved in tumor-associated inflammatory reactions in the pleural compartment by stimulating the proliferation of other inflammatory cells and by releasing inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924471     DOI: 10.1378/chest.106.4.1042

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Evaluation of the phenotype pattern of macrophages isolated from malignant and non-malignant pleural effusions.

Authors:  Mariusz Kaczmarek; Agata Nowicka; Magdalena Kozłowska; Jakub Zurawski; Halina Batura-Gabryel; Jan Sikora
Journal:  Tumour Biol       Date:  2011-08-02

2.  Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space.

Authors:  Elisabetta Pace; Tony F Bruno; Byron Berenger; Christopher H Mody; Mario Melis; Maria Ferraro; Annalisa Tipa; Andreina Bruno; Mirella Profita; Giovanni Bonsignore; Mark Gjomarkaj
Journal:  Immunology       Date:  2007-04-26       Impact factor: 7.397

3.  Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion.

Authors:  Joman Javadi; André Görgens; Hanna Vanky; Dhanu Gupta; Anders Hjerpe; Samir El-Andaloussi; Daniel Hagey; Katalin Dobra
Journal:  Biomolecules       Date:  2021-10-29

4.  Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization.

Authors:  Lucia Maria Zanatta de Aguiar; Leila Antonangelo; Francisco S Vargas; Maria Cláudia Nogueira Zerbini; Maria Mirtes Sales; David E Uip; Paulo Hilário Nascimento Saldiva
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

5.  Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis.

Authors:  A Hamzaoui; K Hamzaoui; A Kahan; A Chabbou
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.